LODELCIZUMAB
UNII 0I24CHI2Z0

Substance Identification & Data

This profile provides standardized clinical and technical data for Lodelcizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0I24CHI2Z0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1355338-54-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0I24CHI2Z0
CAS Registry Number
1355338-54-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LODELCIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9733
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lodelcizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LODELCIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9)), HUMANIZED MONOCLONAL ANTIBODY
LODELCIZUMAB [INN]
LODELCIZUMAB [WHO-DD]